언어 선택

DNA

DNA 제품 목록

속성
Kits (20)
제품 라이브러리
온라인 (20)
종
E. coli (1)CHO (1)- (6)HEK293 (1)E1A & SV40LTA (1)E1A (1)Plasmid DNA (1)HEK293T (1)Pichia (1)Mycoplasma (2)Vero (1)Virus (1)Human (2)
태그
- (20)
마커
- (20)

제품 번호	종	발현 시스템	제품 설명
HOT OPA-O002	E. coli	-	resDetect™ E. coli resDNA Quantitative Kit (qPCR)
HOT OPA-R004	CHO	-	resDetect™ CHO resDNA Quantitation Kit (qPCR)
HOT OPA-R005	-	-	resDetect™ resDNA Sample Preparation Kit (Magnetic Beads)
HOT OPA-S102	Mycoplasma	-	SAFENSURE™ Mycoplasma Rapid Detection Kit (qPCR)
OPA-R031	Human	-	resDetect™ HEK293 resDNA Ultra-Low Quantitation Kit (qPCR)
OPA-R032	Human	-	resDetect™ HEK293T resDNA Ultra-Low Quantitation Kit (qPCR)
OPA-E101	Mycoplasma	-	SAFENSURE™ Mycoplasma DNA Sample Preparation Kit (Magnetic beads)
OPA-E102	-	-	SAFENSURE™ Sterility Sample Preparation Kit (Magnetic beads)
OPA-R006	HEK293	-	resDetect™ HEK293 resDNA Quantitation Kit (qPCR)
OPA-R007	E1A & SV40LTA	-	resDetect™ E1A&SV40LTA resDNA Quantitation Kit (qPCR)

총 수량20

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
BI-836858	BI-836858	Phase 2 Clinical	C.H. Boehringer Sohn Ag & Co. Kg	Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	상세
CART-33 (Chinese PLA General Hospital)		Phase 2 Clinical	Pla General Hospital	Leukemia, Myeloid; Leukemia, Myeloid, Acute	상세
Lintuzumab Ac-225 (Actinium Pharmaceuticals)	225Ac-HuM-195; HuM195-Ac-225; AC225-MOAB-M195	Phase 2 Clinical	Pdl Biopharma Inc	Multiple Myeloma; Leukemia, Myeloid, Acute	상세
VBP-301	VBP301; VBP-301	Phase 2 Clinical	Vor Biopharma Inc	Leukemia, Myeloid, Acute	상세
VBP-101	VBP101; VBP-101	Phase 2 Clinical	Vor Biopharma Inc	Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	상세
VCAR-33 (Vor Biopharma)	VCAR-33; VCAR33	Phase 2 Clinical	Vor Biopharma Inc	Leukemia, Myeloid, Acute	상세
MP0533	MP0533	Phase 2 Clinical	Molecular Partners Ag	Leukemia, Myeloid, Acute	상세
CD33 CAR T Cells(Beijing Boren Hospital)		Phase 2 Clinical	Beijing Gao Boren Hospital Co Ltd	Leukemia; Neoplasms; Leukemia, Myeloid, Acute	상세
Emerfetamab	AMG-673; AMG673	Phase 1 Clinical	Amgen Inc	Leukemia, Myeloid, Acute	상세
ICG-136	ICG-136; 123b-33bcCAR	Phase 1 Clinical	Icell Gene Therapeutics (Int'L) Ltd	Leukemia, Myeloid, Acute	상세
Vixtimotamab	T-564; AMV-564	Phase 1 Clinical	Amphivena Therapeutics Inc	Solid tumours; Myelodysplastic Syndromes	상세
AL-003	AL-003	Phase 1 Clinical	Abbvie Inc, Alector Inc	Alzheimer Disease	상세
PRGN-3006	PRGN-3006	Phase 1 Clinical	Precigen Inc	Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	상세
IM73 chimeric antigen receptor T cell therapy	IM-73-CAR-T	Phase 1 Clinical	Beijing Immunochina Medical Science & Technology Co Ltd	Leukemia, Myeloid, Acute	상세
ORM-6151	ORM-6151	Phase 1 Clinical	Orum Therapeutics Inc	Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	상세
SENTI-202	SENTI-202	Phase 1 Clinical	Senti Biosciences Inc	Hematologic Neoplasms; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	상세
JNJ-67571244	JNJ-67571244; JNJ-67371244; JNJ-1244	Phase 1 Clinical	Johnson & Johnson	Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	상세
CD33-NKE	CD33-NKE; CD33 NKE	Phase 1 Clinical	Bristol-Myers Squibb Company	Leukemia, Myeloid, Acute	상세
Optimised CD33 (FL-33) CAR T Therapy(Beijing GoBroad Hospital)		Phase 1 Clinical	Beijing GoBroad Hospital	Leukemia, Myeloid, Acute	상세
Universal CAR-T Cells therapy(Shenzhen Geno-Immune Medical Institute)		Phase 1 Clinical	Shenzhen Geno-Immune Medical Institute	Leukemia, Myeloid, Acute	상세
CD33/CLL1 dual CAR-NK cell therapy(Institute Of Hematology & Blood Diseases Hospital)		Phase 1 Clinical	Institute Of Hematology & Blood Diseases Hospital, Hangzhou Qihan Biotechnology Co Ltd	Neoplasm, Residual; Leukemia, Myeloid, Acute	상세
CD33 CAR-NK cell therapy(Institute Of Hematology & Blood Diseases Hospital)		Phase 1 Clinical	Institute Of Hematology & Blood Diseases Hospital, Hangzhou Qihan Biotechnology Co Ltd	Neoplasm, Residual; Leukemia, Myeloid, Acute	상세
IMGN-779	IMGN-779	Phase 1 Clinical	Immunogen Inc	Leukemia, Myeloid, Acute	상세
Eluvixtamab	MT-114; AMG-330	Phase 1 Clinical	Amgen Inc	Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	상세
IBR-733	IBR-733; IBR733	Phase 1 Clinical	Imbioray (Hangzhou) Biomedicine Co Ltd	Leukemia, Myeloid, Acute	상세
CD33 CAR-T Therapy (Zhejiang University)		Phase 1 Clinical	Zhejiang University	Leukemia, Myeloid, Acute	상세
CLL1+CD33 CAR-T(Zhejiang University)		Phase 1 Clinical	Zhejiang University	Leukemia, Myeloid, Acute	상세
anti-CD33 CAR T cells therapy（iCell Gene Therapeutics）		Phase 1 Clinical	Icell Gene Therapeutics (Int'L) Ltd	Hematologic Neoplasms; Leukemia, Myeloid, Acute	상세
Anti-CD33/CLL1 CAR-NK Cell Therapy		Phase 1 Clinical	Imbioray (Hangzhou) Biomedicine Co Ltd	Leukemia, Myeloid, Acute	상세
Lintuzumab Ac-225/Venetoclax		Phase 1 Clinical	Actinium Pharmaceuticals Inc	Leukemia, Promyelocytic, Acute	상세
DXC-007(Hangzhou Dac Biotech Company)	DXC-007	Phase 1 Clinical	Hangzhou Dac Biotech Company Ltd	Leukemia; Leukemia, Myeloid, Acute	상세
Lintuzumab-gelonin conjugate		Phase 1 Clinical	The University Of Texas MD Anderson Cancer Center	Leukemia, Myelogenous, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	상세
Anti-CD33/CLL-1 CAR-T (Legend)		Phase 1 Clinical	Legend Biotech Corp	Leukemia, Promyelocytic, Acute	상세
Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD)		Phase 1 Clinical	University Of California San Diego	Leukemia, Myeloid, Acute	상세
Anti-CD33 CAR T cell therapy (Wuhan Bio-Raid)		Clinical	Wuhan BioRaid Biotechnology Co Ltd	Leukemia, Myeloid, Acute	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Gemtuzumab ozogamicin	CMA-676; CDP-771; WAY-CMA-676; CL-555201; hP67.6-calicheamicin	Approved	Ucb Sa, Pfizer Inc	Mylotarg	Japan	Leukemia, Myeloid, Acute	Pfizer Inc	2008-01-18	Leukemia; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Juvenile; Leukemia, Lymphocytic, Chronic, B-Cell	상세